CHAPTER 3
Biocatalytic Synthesis of Small Molecules – Past, Present and Future
Roland Wohlgemuth
Pages 77 - 97
CHAPTER 5
Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs
Ramesh N. Patel
Pages 125 - 167
CHAPTER 9
GSK: Biocatalyst Discovery and Optimisation
Marcelo Kern, Gheorghe-Doru Roiban, Andrew Fosberry and Radka Snajdrova
Pages 257 - 275
CHAPTER 10
PETROBRAS: Efforts on Biocatalysis for Fuels and Chemicals Production
Aline Machado de Castro and José André Cavalcanti da Silva
Pages 276 - 297
CHAPTER 12
LentiKat’s: Industrial Biotechnology, Experiences and Visions
Radek Stloukal, Jarmila Watzková and Kristýna Turková
Pages 323 - 344
CHAPTER 13
EziG: A Universal Platform for Enzyme Immobilisation
Karim Engelmark Cassimjee and Hans-Jürgen Federsel
Pages 345 - 362
CHAPTER 14
Cross-linked Enzyme Aggregates (CLEAs): From Concept to Industrial Biocatalyst
Roger A. Sheldon
Pages 363 - 396
CHAPTER 16
Microvi: MicroNiche Engineering™ for Biocatalysis in the Water and Chemical Industries
Ameen Razavi and Fatemeh Shirazi
Pages 431 - 458
Subject Index
Pages 497 - 511
Publication details
https://doi.org/10.1039/9781782629993
Print publication date:
09 Nov 2017
Copyright year:
2018
Print ISBN:
978-1-78262-619-0
PDF eISBN:
978-1-78262-999-3
ePub eISBN:
978-1-78801-246-1
About this book
Implementing biocatalytic strategies in an industrial setting at a commercial scale is a challenging task, necessitating a balance between industrial need against economic viability. With invited contributions from small and large-scale chemical and pharmaceutical companies, this book bridges the gap between academia and industry. Contributors discuss current processes, types of biocatalysts and improvements, industrial motivation and key aspects to economically succeed. With its focus on industry related issues, this book will be a useful tool for future research by both practitioners and academics.